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Background
Systemic autoinflammatory diseases (SAIDs) are a group
of diseases characterized by episodes of inflammation,
usually manifested with fever and a variety of symptoms,
including skin-rash, arthritis and abdominal pain. A
clinical overlap between different SAIDs, may cause
diagnosis uncertainty. Familial Mediterranean fever
(FMF), the prototype of the autoinflammatory syn-
drome, is manifested with recurrent attacks of fever and
serositis. Although most FMF patients present with a
typical picture, approximately 10% of them, present with
atypical phenotype, and may harbor no mutations in
their MEFV gene. In these patients further genetic ana-
lysis may be advocated.
Objectives
In this study we aimed to study the frequency of gene
mutations of 3 SAIDs in a population of atypical FMF
patients.
Patients and methods
By reviewing our records of FMF patients at Tel-Hashomer,
we identified 10 patients with atypical FMF phenotype, who
were non-responsive to colchicine, and carried no MEFV
mutations. In these patients, we tested genetic mutations
for TNF-receptor associated periodic syndrome (TRAPS),
Hyper IgD Syndrome (HIDS), caused by Mevalonate kinase
(MVK) deficiency and Cryopyrin associated periodic syn-
drome (CAPS).
Results
Of the 10 patients who were recruited, 9 patients were
found not to carry TRAPS, CAPS or HIDS mutations and
1 was heterozygous for the NLRP3 mutation K705Q, con-
sidered a non-pathogenic polymorphism. This patient had
recurrent attacks of fever and skin-rash, without attacks of
serositis. Since some patients with this polymorphism and
SAID’s symptoms were reported to respond to anti IL-1
treatment we offered our patients treatment with canaki-
numab, but she declined our advice.
Conclusion
In FMF endemic area, screening of atypical FMF patients
only rarely lead to a detection of another non-FMF SAID.
Published: 28 September 2015
doi:10.1186/1546-0096-13-S1-P26
Cite this article as: Ben-Zvi et al.: Genetic analysis of MEFV mutation
negative familial Mediterranean fever for non-MEFV mutations is rarely
effective. Pediatric Rheumatology 2015 13(Suppl 1):P26.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sheba Medical Center, Internal Medicine F, Ramat-Gan, Israel
Ben-Zvi et al. Pediatric Rheumatology 2015, 13(Suppl 1):P26
http://www.ped-rheum.com/content/13/S1/P26
© 2015 Ben-Zvi et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
